| Title : The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study - Remijn-Nelissen_2022_Neuromuscul.Disord__ |
| Author(s) : Remijn-Nelissen L , Verschuuren J , Tannemaat MR |
| Ref : Neuromuscular Disorders , : , 2022 |
| Abstract : |
| PubMedSearch : Remijn-Nelissen_2022_Neuromuscul.Disord__ |
| PubMedID: 36184373 |
| Title : Myasthenia gravis - Gilhus_2019_Nat.Rev.Dis.Primers_5_30 |
| Author(s) : Gilhus NE , Tzartos S , Evoli A , Palace J , Burns TM , Verschuuren J |
| Ref : Nat Rev Dis Primers , 5 :30 , 2019 |
| Abstract : |
| PubMedSearch : Gilhus_2019_Nat.Rev.Dis.Primers_5_30 |
| PubMedID: 31048702 |
| Title : Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis - Phillips_2015_Exp.Neurol_270_29 |
| Author(s) : Phillips WD , Christadoss P , Losen M , Punga AR , Shigemoto K , Verschuuren J , Vincent A |
| Ref : Experimental Neurology , 270 :29 , 2015 |
| Abstract : |
| PubMedSearch : Phillips_2015_Exp.Neurol_270_29 |
| PubMedID: 25542979 |